Home LiteratureArticle Details
PMID: 20220143 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S.

A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor.

The Journal of biological chemistry ·Vol. 285 ·No. 23 ·2010-06-04 ·Pages 17954-64

Hurst DP, Grossfield A, Lynch DL, Feller S, Romo TD, Gawrisch K, Pitman MC, Reggio PH

Abstract

Recent isothiocyanate covalent labeling studies have suggested that a classical cannabinoid, (-)-7'-isothiocyanato-11-hydroxy-1',1'dimethylheptyl-hexahydrocannabinol (AM841), enters the cannabinoid CB2 receptor via the lipid bilayer (Pei, Y., Mercier, R. W., Anday, J. K., Thakur, G. A., Zvonok, A. M., Hurst, D., Reggio, P. H., Janero, D. R., and Makriyannis, A. (2008) Chem. Biol. 15, 1207-1219). However, the sequence of steps involved in such a lipid pathway entry has not yet been elucidated. Here, we test the hypothesis that the endogenous cannabinoid sn-2-arachidonoylglycerol (2-AG) attains access to the CB2 receptor via the lipid bilayer. To this end, we have employed microsecond time scale all-atom molecular dynamics (MD) simulations of the interaction of 2-AG with CB2 via a palmitoyl-oleoyl-phosphatidylcholine lipid bilayer. Results suggest the following: 1) 2-AG first partitions out of bulk lipid at the transmembrane alpha-helix (TMH) 6/7 interface; 2) 2-AG then enters the CB2 receptor binding pocket by passing between TMH6 and TMH7; 3) the entrance of the 2-AG headgroup into the CB2 binding pocket is sufficient to trigger breaking of the intracellular TMH3/6 ionic lock and the movement of the TMH6 intracellular end away from TMH3; and 4) subsequent to protonation at D3.49/D6.30, further 2-AG entry into the ligand binding pocket results in both a W6.48 toggle switch change and a large influx of water. To our knowledge, this is the first demonstration via unbiased molecular dynamics that a ligand can access the binding pocket of a class A G protein-coupled receptor via the lipid bilayer and the first demonstration via molecular dynamics of G protein-coupled receptor activation triggered by a ligand binding event.

MeSH Terms
Animals Arachidonic Acids/chemistry Biophysics/methods Cannabinoids/chemistry Cattle Computer Simulation Eicosanoids/chemistry Endocannabinoids Glycerides/chemistry Hydrogen Bonding Ions Ligands Lipid Bilayers/chemistry Lipids/chemistry Protein Binding Receptors, G-Protein-Coupled/chemistry Rhodopsin/chemistry Solvents/chemistry
Chemicals
Arachidonic Acids Cannabinoids Eicosanoids Endocannabinoids Glycerides Ions Ligands Lipid Bilayers Lipids Receptors, G-Protein-Coupled Solvents glyceryl 2-arachidonate Rhodopsin
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Hurst Dow P
Department of Chemistry and Biochemistry, Center for Drug Discovery, University of North Carolina, Greensboro, North Carolina 27402, USA.
Grossfield Alan
Lynch Diane L
Feller Scott
Romo Tod D
Gawrisch Klaus
Pitman Michael C
Reggio Patricia H
References (65)
65 references, click to expand
  1. Constitutive activation of the beta2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment.
    J Biol Chem. 1997 Jul 25;272(30):18546-9 PMID: 9228019
  2. A ligand channel through the G protein coupled receptor opsin.
    PLoS One. 2009;4(2):e4382 PMID: 19194506
  3. A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids.
    Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4888-93 PMID: 16547139
  4. Small angle x-ray diffraction studies on the topography of cannabinoids in synaptic plasma membranes.
    Pharmacol Biochem Behav. 1991 Nov;40(3):547-52 PMID: 1666918
  5. Brain monoglyceride lipase participating in endocannabinoid inactivation.
    Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10819-24 PMID: 12136125
  6. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.
    Science. 2008 Nov 21;322(5905):1211-7 PMID: 18832607
  7. Concerted interconversion between ionic lock substates of the beta(2) adrenergic receptor revealed by microsecond timescale molecular dynamics.
    Biophys J. 2010 Jan 6;98(1):76-84 PMID: 20074514
  8. (-)-7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptor.
    Mol Pharmacol. 2005 Dec;68(6):1623-35 PMID: 16157695
  9. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.
    J Mol Biol. 2004 Sep 10;342(2):571-83 PMID: 15327956
  10. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition.
    FASEB J. 1997 Apr;11(5):346-54 PMID: 9141501
  11. Movement of retinal along the visual transduction path.
    Science. 2000 Jun 23;288(5474):2209-12 PMID: 10864869
  12. Crystal structure of the ligand-free G-protein-coupled receptor opsin.
    Nature. 2008 Jul 10;454(7201):183-7 PMID: 18563085
  13. Molecular characterization of a peripheral receptor for cannabinoids.
    Nature. 1993 Sep 2;365(6441):61-5 PMID: 7689702
  14. Internal hydration increases during activation of the G-protein-coupled receptor rhodopsin.
    J Mol Biol. 2008 Aug 29;381(2):478-86 PMID: 18585736
  15. Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers.
    AAPS J. 2006;8(2):E322-36 PMID: 16796383
  16. Two different forms of metarhodopsin II: Schiff base deprotonation precedes proton uptake and signaling state.
    Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7849-53 PMID: 8356093
  17. Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation.
    J Biol Chem. 2004 Nov 12;279(46):48024-37 PMID: 15326174
  18. Structure of a beta1-adrenergic G-protein-coupled receptor.
    Nature. 2008 Jul 24;454(7203):486-91 PMID: 18594507
  19. Conformational complexity of G-protein-coupled receptors.
    Trends Pharmacol Sci. 2007 Aug;28(8):397-406 PMID: 17629961
  20. Observation of "ionic lock" formation in molecular dynamics simulations of wild-type beta 1 and beta 2 adrenergic receptors.
    Biochemistry. 2009 Jun 9;48(22):4789-97 PMID: 19378975
  21. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.
    Science. 2007 Nov 23;318(5854):1258-65 PMID: 17962520
  22. The conformation, location, and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer.
    J Biol Chem. 2005 Aug 19;280(33):29788-95 PMID: 15964843
  23. Evidence for specificity in lipid-rhodopsin interactions.
    J Biol Chem. 2006 Nov 3;281(44):33233-41 PMID: 16959786
  24. Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor.
    Proc Natl Acad Sci U S A. 2001 May 22;98(11):5997-6002 PMID: 11353823
  25. Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling.
    J Biol Chem. 2001 Mar 23;276(12):9279-90 PMID: 11118431
  26. Two protonation switches control rhodopsin activation in membranes.
    Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17795-800 PMID: 18997017
  27. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
    Biochem Pharmacol. 1995 Jun 29;50(1):83-90 PMID: 7605349
  28. Crystal structure of opsin in its G-protein-interacting conformation.
    Nature. 2008 Sep 25;455(7212):497-502 PMID: 18818650
  29. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor.
    Nature. 2007 Nov 15;450(7168):383-7 PMID: 17952055
  30. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin.
    Science. 1996 Nov 1;274(5288):768-70 PMID: 8864113
  31. Residues accessible in the binding-site crevice of transmembrane helix 6 of the CB2 cannabinoid receptor.
    Biochemistry. 2008 Dec 30;47(52):13811-21 PMID: 19053233
  32. The difference between the CB(1) and CB(2) cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN55212-2 for CB(2).
    Mol Pharmacol. 1999 Oct;56(4):834-40 PMID: 10496968
  33. The molecular logic of endocannabinoid signalling.
    Nat Rev Neurosci. 2003 Nov;4(11):873-84 PMID: 14595399
  34. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
    Science. 2007 Nov 23;318(5854):1266-73 PMID: 17962519
  35. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
    Biochem Biophys Res Commun. 1995 Oct 4;215(1):89-97 PMID: 7575630
  36. Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state.
    Biochemistry. 1996 Aug 27;35(34):11149-59 PMID: 8780519
  37. Identification and functional characterization of brainstem cannabinoid CB2 receptors.
    Science. 2005 Oct 14;310(5746):329-32 PMID: 16224028
  38. Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch.
    J Biol Chem. 2002 Oct 25;277(43):40989-96 PMID: 12167654
  39. Targeting the endocannabinoid system: to enhance or reduce?
    Nat Rev Drug Discov. 2008 May;7(5):438-55 PMID: 18446159
  40. Protonation states of membrane-embedded carboxylic acid groups in rhodopsin and metarhodopsin II: a Fourier-transform infrared spectroscopy study of site-directed mutants.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10206-10 PMID: 7901852
  41. VMD: visual molecular dynamics.
    J Mol Graph. 1996 Feb;14(1):33-8, 27-8 PMID: 8744570
  42. All-atom empirical potential for molecular modeling and dynamics studies of proteins.
    J Phys Chem B. 1998 Apr 30;102(18):3586-616 PMID: 24889800
  43. FRET-based monitoring of conformational change of the beta2 adrenergic receptor in living cells.
    Biochem Biophys Res Commun. 2006 May 19;343(4):1191-6 PMID: 16580633
  44. Retinal counterion switch mechanism in vision evaluated by molecular simulations.
    J Am Chem Soc. 2006 Dec 27;128(51):16502-3 PMID: 17177390
  45. Cysteine 2.59(89) in the second transmembrane domain of human CB2 receptor is accessible within the ligand binding crevice: evidence for possible CB2 deviation from a rhodopsin template.
    Mol Pharmacol. 2005 Jul;68(1):69-83 PMID: 15840841
  46. Molecular-level organization of saturated and polyunsaturated fatty acids in a phosphatidylcholine bilayer containing cholesterol.
    Biochemistry. 2004 Dec 14;43(49):15318-28 PMID: 15581344
  47. Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6.
    J Biol Chem. 2001 Aug 3;276(31):29171-7 PMID: 11375997
  48. Sequence of late molecular events in the activation of rhodopsin.
    Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20290-5 PMID: 18077356
  49. Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations.
    Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4689-94 PMID: 19258456
  50. Crystal structure of rhodopsin: A G protein-coupled receptor.
    Science. 2000 Aug 4;289(5480):739-45 PMID: 10926528
  51. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
    Eur J Biochem. 1995 Aug 15;232(1):54-61 PMID: 7556170
  52. Dynamic structure of retinylidene ligand of rhodopsin probed by molecular simulations.
    J Mol Biol. 2007 Sep 28;372(4):906-17 PMID: 17719606
  53. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
    J Neurosci. 2003 Dec 3;23(35):11136-41 PMID: 14657172
  54. Role of the highly conserved Asp-Arg-Tyr motif in signal transduction of the CB2 cannabinoid receptor.
    FEBS Lett. 2000 Jan 28;466(2-3):300-4 PMID: 10682848
  55. Role of cholesterol and polyunsaturated chains in lipid-protein interactions: molecular dynamics simulation of rhodopsin in a realistic membrane environment.
    J Am Chem Soc. 2005 Apr 6;127(13):4576-7 PMID: 15796514
  56. Functional microdomains in G-protein-coupled receptors. The conserved arginine-cage motif in the gonadotropin-releasing hormone receptor.
    J Biol Chem. 1998 Apr 24;273(17):10445-53 PMID: 9553103
  57. The effect of pH on beta(2) adrenoceptor function. Evidence for protonation-dependent activation.
    J Biol Chem. 2000 Feb 4;275(5):3121-7 PMID: 10652295
  58. Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation.
    Chem Biol. 2008 Nov 24;15(11):1207-19 PMID: 19022181
  59. Location, structure, and dynamics of the synthetic cannabinoid ligand CP-55,940 in lipid bilayers.
    Biophys J. 2009 Jun 17;96(12):4916-24 PMID: 19527650
  60. The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors.
    FEBS Lett. 2006 Oct 2;580(22):5392-8 PMID: 16989818
  61. Complex salt bridges in proteins: statistical analysis of structure and function.
    J Mol Biol. 1995 Dec 8;254(4):761-70 PMID: 7500348
  62. Structure of bovine rhodopsin in a trigonal crystal form.
    J Mol Biol. 2004 Nov 5;343(5):1409-38 PMID: 15491621
  63. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography.
    Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):5982-7 PMID: 11972040
  64. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin.
    J Biol Chem. 1994 Sep 30;269(39):23879-81 PMID: 7929034
  65. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.
    Pharmacol Rev. 2002 Jun;54(2):161-202 PMID: 12037135
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
1083-351X
Published
2010-06-04
Epub
2010-00-10
Pages
17954-64
Language
English
Region
United States
NLM ID
2985121R
PMCID
PMC2878557
Subset
IM
Grants
NIDA NIH HHS · K05 DA021358 · United States
Intramural NIH HHS · United States
NIDA NIH HHS · DA021358 · United States
NIDA NIH HHS · R01 DA003934 · United States
NIDA NIH HHS · DA003934 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com